Información del producto
Información adicional
Storage Conditions
-20°C/1 year
Applications
ELISA
WB
WB
Concentration
1 mg/ml
Recomended Dilution
Western Blot: 1/500 - 1/2000. ELISA: 1/40000. Not yet tested in other applications.
Type Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human TNFAIP8L2. AA range:11-60
Subcellular Location
cytoplasm,
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Rat
Mouse
Rat
Human Gen
79626
Observed Band
20kD
Other Name
Inflammation factor protein 20
TIPE2
TNFAIP8-like protein 2
TNFAIP8L2
TNF alpha-induced protein 8-like protein 2
Tumor necrosis factor alpha-induced protein 8-like protein 2
TIPE2
TNFAIP8-like protein 2
TNFAIP8L2
TNF alpha-induced protein 8-like protein 2
Tumor necrosis factor alpha-induced protein 8-like protein 2
Background
domain:The central region was initially thought to constitute a DED (death effector) domain. However, 3D-structure data reveal a previously uncharacterized fold that is different from the predicted fold of a DED (death effector) domain. It consists of a l
however, such result is unclear since PubMed:19079267 could not reproduce the interaction with CASP8.,
however, such result is unclear since PubMed:19079267 could not reproduce the interaction with CASP8.,